Spera Pharma Begins Business Capitalizing on “Takeda’s” Track Record, Aims to Become Japan’s No. 1 CDMO

Spera Pharma President Toshio Yoshioka Spera Pharma, which took over part of Takeda Pharmaceutical’s Pharmaceutical Sciences (chemistry, manufacturing, and control) business amid the drug giant's R&D revamp, started its operations in July, aiming to obtain orders from drug makers by...read more